Literature DB >> 22134126

Design and self-assembly of siRNA-functionalized RNA nanoparticles for use in automated nanomedicine.

Kirill A Afonin1, Wade W Grabow, Faye M Walker, Eckart Bindewald, Marina A Dobrovolskaia, Bruce A Shapiro, Luc Jaeger.   

Abstract

Individual genes can be targeted with siRNAs. The use of nucleic acid nanoparticles (NPs) is a convenient method for delivering combinations of specific siRNAs in an organized and programmable manner. We present three assembly protocols to produce two different types of RNA self-assembling functional NPs using processes that are fully automatable. These NPs are engineered based on two complementary nanoscaffold designs (nanoring and nanocube), which serve as carriers of multiple siRNAs. The NPs are functionalized by the extension of up to six scaffold strands with siRNA duplexes. The assembly protocols yield functionalized RNA NPs, and we show that they interact in vitro with human recombinant Dicer to produce siRNAs. Our design strategies allow for fast, economical and easily controlled production of endotoxin-free therapeutic RNA NPs that are suitable for preclinical development.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22134126      PMCID: PMC3498981          DOI: 10.1038/nprot.2011.418

Source DB:  PubMed          Journal:  Nat Protoc        ISSN: 1750-2799            Impact factor:   13.491


  61 in total

1.  TectoRNA: modular assembly units for the construction of RNA nano-objects.

Authors:  L Jaeger; E Westhof; N B Leontis
Journal:  Nucleic Acids Res       Date:  2001-01-15       Impact factor: 16.971

2.  Recombinant Dicer efficiently converts large dsRNAs into siRNAs suitable for gene silencing.

Authors:  Jason W Myers; Joshua T Jones; Tobias Meyer; James E Ferrell
Journal:  Nat Biotechnol       Date:  2003-02-18       Impact factor: 54.908

Review 3.  RNA interference.

Authors:  Gregory J Hannon
Journal:  Nature       Date:  2002-07-11       Impact factor: 49.962

4.  Short double-stranded ribonucleic acid as inhibitor of gene expression by the interference mechanism.

Authors:  Jean-Rémi Bertrand; Andrei Maksimenko; Claude Malvy
Journal:  Methods Mol Biol       Date:  2005

5.  Multistrand RNA secondary structure prediction and nanostructure design including pseudoknots.

Authors:  Eckart Bindewald; Kirill Afonin; Luc Jaeger; Bruce A Shapiro
Journal:  ACS Nano       Date:  2011-11-17       Impact factor: 15.881

6.  Building programmable jigsaw puzzles with RNA.

Authors:  Arkadiusz Chworos; Isil Severcan; Alexey Y Koyfman; Patrick Weinkam; Emin Oroudjev; Helen G Hansma; Luc Jaeger
Journal:  Science       Date:  2004-12-17       Impact factor: 47.728

7.  Synthetic dsRNA Dicer substrates enhance RNAi potency and efficacy.

Authors:  Dong-Ho Kim; Mark A Behlke; Scott D Rose; Mi-Sook Chang; Sangdun Choi; John J Rossi
Journal:  Nat Biotechnol       Date:  2004-12-26       Impact factor: 54.908

8.  Efficient silencing of bcr/abl oncogene by single- and double-stranded siRNAs targeted against b2a2 transcripts.

Authors:  Valentina Rapozzi; Luigi Emilio Xodo
Journal:  Biochemistry       Date:  2004-12-28       Impact factor: 3.162

9.  Ribonuclease activity and RNA binding of recombinant human Dicer.

Authors:  Patrick Provost; David Dishart; Johanne Doucet; David Frendewey; Bengt Samuelsson; Olof Rådmark
Journal:  EMBO J       Date:  2002-11-01       Impact factor: 11.598

10.  Single-stranded antisense siRNAs guide target RNA cleavage in RNAi.

Authors:  Javier Martinez; Agnieszka Patkaniowska; Henning Urlaub; Reinhard Lührmann; Thomas Tuschl
Journal:  Cell       Date:  2002-09-06       Impact factor: 41.582

View more
  79 in total

1.  siRNA delivery: Loaded-up microsponges.

Authors:  Wade W Grabow; Luc Jaeger
Journal:  Nat Mater       Date:  2012-03-22       Impact factor: 43.841

Review 2.  Convergent evolution of twintron-like configurations: One is never enough.

Authors:  Mohamed Hafez; Georg Hausner
Journal:  RNA Biol       Date:  2015       Impact factor: 4.652

3.  Computational docking simulations of a DNA-aptamer for argininamide and related ligands.

Authors:  H Bauke Albada; Eyal Golub; Itamar Willner
Journal:  J Comput Aided Mol Des       Date:  2015-04-16       Impact factor: 3.686

4.  Multistrand RNA secondary structure prediction and nanostructure design including pseudoknots.

Authors:  Eckart Bindewald; Kirill Afonin; Luc Jaeger; Bruce A Shapiro
Journal:  ACS Nano       Date:  2011-11-17       Impact factor: 15.881

5.  Bolaamphiphiles as carriers for siRNA delivery: From chemical syntheses to practical applications.

Authors:  Kshitij Gupta; Kirill A Afonin; Mathias Viard; Virginia Herrero; Wojciech Kasprzak; Ioannis Kagiampakis; Taejin Kim; Alexey Y Koyfman; Anu Puri; Marissa Stepler; Alison Sappe; Vineet N KewalRamani; Sarina Grinberg; Charles Linder; Eliahu Heldman; Robert Blumenthal; Bruce A Shapiro
Journal:  J Control Release       Date:  2015-07-04       Impact factor: 9.776

6.  Non-covalent Encapsulation of siRNA with Cell-Penetrating Peptides.

Authors:  Martina Tuttolomondo; Henrik J Ditzel
Journal:  Methods Mol Biol       Date:  2021

7.  Cotranscriptional Production of Chemically Modified RNA Nanoparticles.

Authors:  Maria L Kireeva; Kirill A Afonin; Bruce A Shapiro; Mikhail Kashlev
Journal:  Methods Mol Biol       Date:  2017

8.  Intracellular Reassociation of RNA-DNA Hybrids that Activates RNAi in HIV-Infected Cells.

Authors:  Angelica N Martins; Weina Ke; Vaishnavi Jawahar; Morriah Striplin; Caryn Striplin; Eric O Freed; Kirill A Afonin
Journal:  Methods Mol Biol       Date:  2017

9.  Peptide-MHC-based nanomedicines for autoimmunity function as T-cell receptor microclustering devices.

Authors:  Santiswarup Singha; Kun Shao; Yang Yang; Xavier Clemente-Casares; Patricia Solé; Antonio Clemente; Jesús Blanco; Qin Dai; Fayi Song; Shang Wan Liu; Jun Yamanouchi; Channakeshava Sokke Umeshappa; Roopa Hebbandi Nanjundappa; Pascal Detampel; Matthias Amrein; César Fandos; Robert Tanguay; Susan Newbigging; Pau Serra; Anmar Khadra; Warren C W Chan; Pere Santamaria
Journal:  Nat Nanotechnol       Date:  2017-04-24       Impact factor: 39.213

Review 10.  Uniqueness, advantages, challenges, solutions, and perspectives in therapeutics applying RNA nanotechnology.

Authors:  Peixuan Guo; Farzin Haque; Brent Hallahan; Randall Reif; Hui Li
Journal:  Nucleic Acid Ther       Date:  2012-08       Impact factor: 5.486

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.